Quick Heal Technologies Ltd (BOM:539678)
₹ 606.2 -4.95 (-0.81%) Market Cap: 32.68 Bil Enterprise Value: 30.79 Bil PE Ratio: 102.23 PB Ratio: 7.47 GF Score: 72/100

Q2 2025 Quick Heal Technologies Ltd Earnings Call Transcript

Oct 18, 2024 / 10:30AM GMT
Release Date Price: ₹711.3 (-6.49%)

Key Points

Positve
  • Quick Heal Technologies Ltd (BOM:539678) reported a robust 11% growth in revenue and a 238% growth in EBITDA for the first half of FY25.
  • The company launched AntiFraud.AI, a groundbreaking innovation aimed at preventing financial frauds, marking a significant step in consumer protection.
  • Quick Heal's products received multiple accolades, including a perfect score of 18 out of 18 for their endpoint security solution from AV-Test.
  • The company secured a contract with one of the largest logistics companies to modernize their cybersecurity stack, showcasing their competitive edge.
  • Quick Heal Technologies Ltd (BOM:539678) remains a cash-rich company, focused on creating long-term value for shareholders.
Negative
  • The enterprise business experienced a sluggish quarter due to non-closure of key government orders, leading to dampened growth.
  • There was a 6% year-on-year decline in revenue due to a flattish enterprise business and headwinds in the consumer segment.
  • The company's margins have significantly decreased from over 30% to below 10% due to increased R&D spending and market challenges.
  • Despite the launch of new products, the company has not provided specific revenue targets or guidance, leading to uncertainty about future financial performance.
  • The consumer antivirus market is facing headwinds, with overall market degrowth impacting Quick Heal's consumer business.
Operator

Ladies and gentlemen, good day and welcome to the Q2 and H1 FY25 conference call of Quick Heal Technologies Limited, hosted by Valorem Advisors. (Operator Instructions) I now hand the conference over to Ms. Purvangi Jain from Valorem Advisors. Thank you and over to you, ma'am.

Purvangi Jain
Valorem Advisors Ltd. - Analyst

Good evening, everyone and a warm welcome to you all. My name is Purvangi Jain from Valorem Advisors. We represent the Investor Relations of Quick Heal Technologies Limited. On behalf of the company, I would like to thank you all for participating in the company's earnings call for the second quarter of the financial year 2025.

Before we begin a quick cautionary statement. Some of the statements made in today's earnings conference call may be forward-looking in nature. Such forward-looking statements are subject to risk and uncertainties, which could cause actual results to differ from those anticipated.

Such statements are based on management's beliefs as well as assumptions made by and information currently available to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot